114 related articles for article (PubMed ID: 12381912)
1. Unexpected renal actions of erythropoietin.
Westenfelder C
Exp Nephrol; 2002; 10(5-6):294-8. PubMed ID: 12381912
[TBL] [Abstract][Full Text] [Related]
2. Human, rat, and mouse kidney cells express functional erythropoietin receptors.
Westenfelder C; Biddle DL; Baranowski RL
Kidney Int; 1999 Mar; 55(3):808-20. PubMed ID: 10027918
[TBL] [Abstract][Full Text] [Related]
3. Effects of erythropoietin receptor activity on angiogenesis, tubular injury, and fibrosis in acute kidney injury: a "U-shaped" relationship.
Shi M; Flores B; Li P; Gillings N; McMillan KL; Ye J; Huang LJ; Sidhu SS; Zhong YP; Grompe MT; Streeter PR; Moe OW; Hu MC
Am J Physiol Renal Physiol; 2018 Apr; 314(4):F501-F516. PubMed ID: 29187371
[TBL] [Abstract][Full Text] [Related]
4. Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure.
Johnson DW; Pat B; Vesey DA; Guan Z; Endre Z; Gobe GC
Kidney Int; 2006 May; 69(10):1806-13. PubMed ID: 16598197
[TBL] [Abstract][Full Text] [Related]
5. Discovering erythropoietin's extra-hematopoietic functions: biology and clinical promise.
Brines M; Cerami A
Kidney Int; 2006 Jul; 70(2):246-50. PubMed ID: 16738535
[TBL] [Abstract][Full Text] [Related]
6. Amelioration of lipopolysaccharide-induced acute kidney injury by erythropoietin: involvement of mitochondria-regulated apoptosis.
Stoyanoff TR; Todaro JS; Aguirre MV; Zimmermann MC; Brandan NC
Toxicology; 2014 Apr; 318():13-21. PubMed ID: 24561306
[TBL] [Abstract][Full Text] [Related]
7. Erythropoietin stimulates proliferation of human renal carcinoma cells.
Westenfelder C; Baranowski RL
Kidney Int; 2000 Aug; 58(2):647-57. PubMed ID: 10916088
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin-enhanced endothelial progenitor cell recruitment in peripheral blood and renal vessels during experimental acute kidney injury in rats.
Cakiroglu F; Enders-Comberg SM; Pagel H; Rohwedel J; Lehnert H; Kramer J
Cell Biol Int; 2016 Mar; 40(3):298-307. PubMed ID: 26616141
[TBL] [Abstract][Full Text] [Related]
9. Effect and mechanism of erythropoietin on mesenchymal stem cell proliferation in vitro under the acute kidney injury microenvironment.
Liu N; Tian J; Wang W; Cheng J; Hu D; Zhang J
Exp Biol Med (Maywood); 2011 Sep; 236(9):1093-9. PubMed ID: 21865406
[TBL] [Abstract][Full Text] [Related]
10. Novel renoprotective actions of erythropoietin: new uses for an old hormone.
Johnson DW; Forman C; Vesey DA
Nephrology (Carlton); 2006 Aug; 11(4):306-12. PubMed ID: 16889570
[TBL] [Abstract][Full Text] [Related]
11. Erythropoietin in experimental acute renal failure.
Sharples EJ; Yaqoob MM
Nephron Exp Nephrol; 2006; 104(3):e83-8. PubMed ID: 16837817
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin enhances recovery after cisplatin-induced acute renal failure in the rat.
Bagnis C; Beaufils H; Jacquiaud C; Adabra Y; Jouanneau C; Le Nahour G; Jaudon MC; Bourbouze R; Jacobs C; Deray G
Nephrol Dial Transplant; 2001 May; 16(5):932-8. PubMed ID: 11328897
[TBL] [Abstract][Full Text] [Related]
13. The expression of EPOR in renal cortex during postnatal development.
Xiao L; Li Z; Xu P; Li Z; Xu J; Yang Z
PLoS One; 2012; 7(7):e41993. PubMed ID: 22844537
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin attenuates renal and pulmonary injury in polymicrobial induced-sepsis through EPO-R, VEGF and VEGF-R2 modulation.
Heitrich M; García DM; Stoyanoff TR; Rodríguez JP; Todaro JS; Aguirre MV
Biomed Pharmacother; 2016 Aug; 82():606-13. PubMed ID: 27470403
[TBL] [Abstract][Full Text] [Related]
15. The administration of erythropoietin attenuates kidney injury induced by ischemia/reperfusion with increased activation of Wnt/β-catenin signaling.
Chen X; Wang CC; Song SM; Wei SY; Li JS; Zhao SL; Li B
J Formos Med Assoc; 2015 May; 114(5):430-7. PubMed ID: 25682558
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietin in polycystic kidneys.
Eckardt KU; Möllmann M; Neumann R; Brunkhorst R; Burger HU; Lonnemann G; Scholz H; Keusch G; Buchholz B; Frei U
J Clin Invest; 1989 Oct; 84(4):1160-6. PubMed ID: 2794053
[TBL] [Abstract][Full Text] [Related]
17. Experimental models of acute renal failure and erythropoietin: what evidence of a direct effect?
Sturiale A; Campo S; Crascì E; Aloisi C; Buemi M
Ren Fail; 2007; 29(3):379-86. PubMed ID: 17497457
[TBL] [Abstract][Full Text] [Related]
18. Recombinant erythropoietin rapidly treats anemia in ischemic acute renal failure.
Nemoto T; Yokota N; Keane WF; Rabb H
Kidney Int; 2001 Jan; 59(1):246-51. PubMed ID: 11135077
[TBL] [Abstract][Full Text] [Related]
19. Cadmium and cisplatin damage erythropoietin-producing proximal renal tubular cells.
Horiguchi H; Oguma E; Kayama F
Arch Toxicol; 2006 Oct; 80(10):680-6. PubMed ID: 16555044
[TBL] [Abstract][Full Text] [Related]
20. Carbamylated Erythropoietin Outperforms Erythropoietin in the Treatment of AKI-on-CKD and Other AKI Models.
Tögel FE; Ahlstrom JD; Yang Y; Hu Z; Zhang P; Westenfelder C
J Am Soc Nephrol; 2016 Nov; 27(11):3394-3404. PubMed ID: 26984884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
